These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23672411)

  • 1. Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer.
    Muenst S; Obermann EC; Gao F; Oertli D; Viehl CT; Weber WP; Fleming T; Gillanders WE; Soysal SD
    Histopathology; 2013 Jul; 63(1):74-82. PubMed ID: 23672411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis.
    Zhou X; Coad J; Ducatman B; Agazie YM
    Histopathology; 2008 Oct; 53(4):389-402. PubMed ID: 18643929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
    Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
    Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation.
    Zhou X; Agazie YM
    J Biol Chem; 2009 May; 284(18):12226-34. PubMed ID: 19261604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.
    Jiang C; Hu F; Tai Y; Du J; Mao B; Yuan Z; Wang Y; Wei L
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):637-46. PubMed ID: 22228034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases.
    Sausgruber N; Coissieux MM; Britschgi A; Wyckoff J; Aceto N; Leroy C; Stadler MB; Voshol H; Bonenfant D; Bentires-Alj M
    Oncogene; 2015 Apr; 34(17):2272-8. PubMed ID: 24931162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.
    Aceto N; Sausgruber N; Brinkhaus H; Gaidatzis D; Martiny-Baron G; Mazzarol G; Confalonieri S; Quarto M; Hu G; Balwierz PJ; Pachkov M; Elledge SJ; van Nimwegen E; Stadler MB; Bentires-Alj M
    Nat Med; 2012 Mar; 18(4):529-37. PubMed ID: 22388088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.
    Zhou XD; Agazie YM
    Cell Death Differ; 2008 Jun; 15(6):988-96. PubMed ID: 18421299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
    Matalkah F; Martin E; Zhao H; Agazie YM
    Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of SHP2 in gastric cancer.
    Dong S; Li FQ; Zhang Q; Lv KZ; Yang HL; Gao Y; Yu JR
    J Int Med Res; 2012; 40(6):2083-9. PubMed ID: 23321164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro.
    Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment.
    Zhao H; Agazie YM
    BMC Cancer; 2015 Mar; 15():109. PubMed ID: 25885600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-1 expression has an independent prognostic value in breast cancer.
    Boström P; Söderström M; Vahlberg T; Söderström KO; Roberts PJ; Carpén O; Hirsimäki P
    BMC Cancer; 2011 Aug; 11():348. PubMed ID: 21835023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
    Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
    Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
    Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
    Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear expression of snail is an independent negative prognostic factor in human breast cancer.
    Muenst S; Däster S; Obermann EC; Droeser RA; Weber WP; von Holzen U; Gao F; Viehl C; Oertli D; Soysal SD
    Dis Markers; 2013; 35(5):337-44. PubMed ID: 24191127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    Hartman Z; Geldenhuys WJ; Agazie YM
    J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
    Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
    Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer.
    Martin E; Agazie YM
    Mol Cancer Res; 2021 Nov; 19(11):1946-1956. PubMed ID: 34389690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.